Abstract
Purpose
Pancreatoduodenectomy (PD) with superior mesenteric/portal venous resection (PVR) for pancreatic ductal adenocarcinoma (PDAC) is performed routinely in case of tumor adhesion to the superior mesenteric or portal vein. True histopathological portal vein invasion (PVI) is found in a subgroup of patients. Even though this procedure has become routine in most centers for pancreatic surgery, data on prognostic factors in this situation is limited. The aim of this study was to identify prognostic factors after PD with PVR for PDAC.
Methods
Retrospective analysis was performed on the basis of a prospectively maintained database, and paraffin-embedded formalin-fixed tissue slides stained for hematoxylin-eosin were re-evaluated by two independent pathologists. Statistical analysis was conducted using MedCalc software.
Results
From 2001 to 2012, 86 cases of PD with PVR for PDAC with long-term follow-up and sufficient tissue for re-assessment were identified. Histopathological re-review disclosed PVI in 39 resection specimens and adhesion without infiltration in 47. Overall median survival in all patients was 22 months. Patients with PVI versus no PVI showed comparable baseline demographic and standard histopathological parameters; however, PVI was associated with microscopic hemangiosis (p = 0.001) and positive margin status (p = 0.001). Median survival in patients with PVI was 14 months versus 25 months in patients without PVI (p = 0.042). Only lymph node ratio and PVI were independent predictors of survival after resection.
Conclusion
The only independent factors influencing overall survival after PD with PVR for PDAC were lymph node ratio and PVI. PVI might indicate aggressive tumor biology, but the available data remains controversial.
Similar content being viewed by others
References
Katz MHG, Marsh R, Herman JM et al (2013) Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol 20:2787–2795. doi:10.1245/s10434-013-2886-9
Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg Off J Soc Surg Aliment Tract 14:1442–1452. doi:10.1007/s11605-009-1129-7
Delpero JR, Boher JM, Sauvanet A et al (2015) Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie. Ann Surg Oncol. doi:10.1245/s10434-014-4304-3
Lopez NE, Prendergast C, Lowy AM (2014) Borderline resectable pancreatic cancer: definitions and management. World J Gastroenterol WJG 20:10740–10751. doi:10.3748/wjg.v20.i31.10740
Murakami Y, Satoi S, Motoi F et al (2015) Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Br J Surg 102:837–846. doi:10.1002/bjs.9799
Turrini O, Ewald J, Barbier L et al (2013) Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg 257:726–730. doi:10.1097/SLA.0b013e318269d23c
Castleberry AW, White RR, De La Fuente SG et al (2012) The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol 19:4068–4077. doi:10.1245/s10434-012-2585-y
Worni M, Castleberry AW, Clary BM et al (2013) Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients. JAMA Surg 148:331–338. doi:10.1001/jamasurg.2013.1058
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumors of the digestive system, 4th edn. International Agency for Research in Cancer, Lyon, France
Fuhrman GM, Leach SD, Staley CA et al (1996) Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223:154–162
Leach SD, Lee JE, Charnsangavej C et al (1998) Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85:611–7. doi:10.1046/j.1365-2168.1998.00641.x
Bockhorn M, Uzunoglu FG, Adham M et al (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988. doi:10.1016/j.surg.2014.02.001
Cao HST, Balachandran A, Wang H et al (2014) Radiographic tumor-vein interface as a predictor of intraoperative, pathologic and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 18:269–278. doi:10.1007/s11605-013-2374-3
Gong Y, Zhang L, He T, et al. (2013) Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS ONE. doi: 10.1371/journal.pone.0070340
Müller SA, Hartel M, Mehrabi A et al (2009) Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg Off J Soc Surg Aliment Tract 13:784–792. doi:10.1007/s11605-008-0791-5
Nakao A, Kanzaki A, Fujii T et al (2012) Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 255:103–108. doi:10.1097/SLA.0b013e318237872e
Shimada K, Sano T, Sakamoto Y, Kosuge T (2006) Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol 13:1569–1578. doi:10.1245/s10434-006-9143-4
Wang J, Estrella JS, Peng L et al (2012) Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118:3801–3811. doi:10.1002/cncr.26717
Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–9. doi:10.1097/SLA.0b013e31815aab22
Zhou Y, Zhang Z, Liu Y et al (2012) Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg 36:884–891. doi:10.1007/s00268-012-1461-z
Kelly KJ, Winslow E, Kooby D et al (2013) Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of “borderline resectable disease”? J Gastrointest Surg Off J Soc Surg Aliment Tract 17:1209–1217. doi:10.1007/s11605-013-2178-5, discussion 1217
Verbeke CS (2013) Resection margins in pancreatic cancer. Surg Clin North Am 93:647–662. doi:10.1016/j.suc.2013.02.008
Wang C, Wu H, Xiong J et al (2008) Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:2183–2190. doi:10.1007/s11605-008-0621-9
Wang F, Gill AJ, Neale M et al (2014) Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol 21:1937–1947. doi:10.1245/s10434-014-3554-4
Rehders A, Stoecklein NH, Güray A et al (2012) Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery 152:S143–151. doi:10.1016/j.surg.2012.05.012
Acknowledgments
This study was supported by a research grant from the German Research Council to UFW (DFG-WE 5085/1-1).
Authors’ contributions
• Study conception and design: UFW, PB, DB, and TK
• Acquisition of data: HL, FM, PB, MW, UTH, and UAW
• Analysis and interpretation of data: HL, LB, UFW, and PB
• Drafting of manuscript: HL, LB, PB, UFW, and DB
• Critical revision of manuscript: TK, UTH, UAW, FM, MW, and DB
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Hryhoriy Lapshyn and Peter Bronsert share first authorship.
Ulrich F. Wellner and Dirk Bausch share senior authorship.
Hryhoriy Lapshyn, Peter Bronsert, Ulrich F. Wellner and Dirk Bausch contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lapshyn, H., Bronsert, P., Bolm, L. et al. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Langenbecks Arch Surg 401, 63–69 (2016). https://doi.org/10.1007/s00423-015-1363-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-015-1363-2